TD: Nasal drug delivery Flashcards

1
Q

What is drug delivery to the nasal cavity and what can it be used for?

Why is it useful?

A

Drugs delivered into the nasal cavity for….

  • Localised effect
  • Systemic effect
  • Vaccine delivery

Why? - Usually when oral route is unavailable, localised effect, convenient and accessible route, rapid onset of action, avoid hepatic/GI metabolism, treat chronic disorders, low cost.ose – brain delivery (BBB?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Give examples of conditions the nasal route can be used for and drugs that can target these:

  1. Local
  2. Systemic
  3. Vaccine

What preperations are available?

A

OTC or POM Liquid (solution, emulsion, suspension), gel, ointment, cream, powder

Local Delivery

  • Allergic rhinitis, nasal congestion, nasal infection
  • Antihistamines (Azelastaine hydrochloride), Sympathomimetic (Ephedrine hydrochloride), antibacterials (Mupirocin)
  • Ointment, cream, drops, spray

Systemic Delivery

  • Diabetes, pain, smoking cessation, osteoporosis, prostate cancer, migraine.
  • Hormones (Desmopressin acetate), opioids (Fentanyl citrate), Alkaloid (Nicotine), Polypeptide hormone (Salmon calcitonin), Gonadorelin analogue (Buserelin), 5-HT1 agonist (Sumatriptan).
  • Spray

Vaccines

  • Influenza (live – attenuated) – FlumistTM
  • Pre – filled syringe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the different regions of the nasal cavity?

Describe the nasal cavity anatomy

A
  • Two cavities (each 15ml) - divided by nasal septum
  • Large surface area 160cm 2
  • 120 – 140 mm from nostrils to nasopharynx
  • Contains a broad range of enzymes
  • Turbinate region (80 – 90% surface area) – superior, middle, inferior
  • Continuously secretes mucus (turbinate region)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What gives the turbinate regions its large SA?

What happenens to particles in the turbinate region?

A
  • Inferior / middle / superior folds - give large SA
  • Turbulent air flow – hits walls, deposits particles
    • Hot air breathed in and carriers particles to turbinate region. Mucus here sweeps particles to nasaopharynx where particles swallowed or coughed up
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The following refers to the turbinate region. Fill in the gaps:

  1. •It has convoluted projections -
  2. •Rich supply of
  3. •Main site of
A
  1. It has convoluted projections - columnar epithelium
  2. Rich supply of blood vessels
  3. Main site of drug absorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are turbinate cells called?

What cells make up these?

What are these cells characterisitics and functions?

A

•Columnar Epithelial cells – goblet/ciliated and non – ciliated / basel cells.

Goblet cells – continuously secrete mucus

  • •Covers epithelium: 1 – 10 µm thick
  • •Above periciliary layer (cilia and microvilli ~ 7 µm)
  • •97% water/3% solids (mucin, proteins, salts, lipids)
  • •pH – 5.5 – 6.5
  • •Barrier to drugs (large molecules)

Ciliated cells – cilia beat and move mucus (Mucociliary Clearance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the 2 mechanisms of absorption of particles?

A

Transcellular Diffusion

  • lipophilic molecules (mainly passive diffusion)
  • Through lipid rich membranes of epithelial cells
  • Endocytosis / active transport: large hydrophobic molecules

Paracellular Diffusion

  • Small hydrophilic molecules (0.39 - 0.84 nm)
  • Through aqueous intercellular spaces between cells – smaller area – slower
  • Rate proportional to molecular size
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are factors affceting absorption?

A

Mucociliary clearance

  • Drugs deposited on mucociliary ‘conveyor belt’ – cleared from nasal cavity – LIMITED CONTACT TIME!
  • Solutions - readily absorbed (lipophilic, low molecular weight) / Suspensions – drug particles must dissolve
  • Reported to be 12 – 15 minutes

Mucus Layer

  • Nasal mucosa protected by muscus = BARRIER TO DRUG DELIVERY
  • Diffusion is a function of molecule size

Enzymic activity

  • Broad range of enzymes – phase I/II metabolism (less than GI tract)
  • Amount of drug, physiochemical properties, rate of clearance, rate of absorption

Epithelial barrier

e.g. efflux transporters actively transport drug back into nasal cavity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are ways to improve drug absorption?

A
  1. Increase Nasal Resistance time - Mucoadhesion
    • Muchoadhesive polymers
    • e.g. Cellulose, starch, chitosan
  2. Increase Drug Solubility
    • change molecular form: Prodrugs, salts, co – solvents, cyclodextins, surfactants
  3. Enzyme Inhibitors
    • Prevent hydrolysis, enhances permeability
  4. Permeation enhancer
    • alter epithelium – improve stability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is mucoadhesion and what is bioadhesion

A

Bioadhesion

­Mechanism by which two biological materials are held together by interfacial forces

­Nasal epithelial surface

Mucoadhesion

­Attachment of a drug carrier system to the mucus layer of a mucosal epithelium to maintain intimate contact for extended periods

­Required to over come mucociliary clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What can be used for mucoadhesion and how do these work?

A
  • ­Mucoadhesive polymers - under go physical or chemical bonding
  • ­Work by: Hydration / carriers / permeability
    • Hydration - Polymer comes into contact with mucus with promotes hydration and extention of polymer chains which hold carrier system in place
    • Carrier - Carries and protects drug (less enzyme degr)
    • Permeability - As polymer hydrations the cells dehydrate and this opens tight junctions
  • ­Powders, liquids, gels - Temp / pH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the stages of mucoadhesion?

A

1.Contact stage

Intimate contact between mucoadhesive and mucosa

  1. Consolidation Stage

Interpenetration: Mucoadhesive penetrates crevices of epithelium – physical bonding between the glycoprotein (responsible for adhesive and cohesive properties of mucus) and polymer chains

Formation of chemical secondary bonds: Van der Waals, hydrogen, hydrophobic interactions (anionic/non – ionic), electrostatic interactions (if cationic – mucus anionic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are other factors affecting absorption

A

Physiochemical Factors Affecting Absorption

• Solubility, concentration, pH, Log P, excipients, pKa, lipophilicity/hydrophobilicity, molecular size

Patient Factors

• Compliance, disease, nasal vascularity, environmental factors

Delivery Device

• Volume, spray, droplet size, site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What factors do you need to consider when developing a nasal prodcut?

A

ØLiquid (solution, gel or suspension), ointment / cream or powdered solid

Ø Physiochemical drug properties: Solubility, concentration, pH, Log P, excipients, pKa, lipophilicity/hydrophobilicity, molecular size

Ø Stability – temp/light, crystal growth, resuspension, homogeneity, uniformity

Ø Particle size distribution (10 – 50µm)

Ø Excipients – as few as possible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are examples of excipients you might want to add and their function

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are examples of delivery devices?

A

Tube

­Creams and ointments, uncontrolled dose, apply with finger, messy, local effect only e.g. mupirocin

Dropper

­Liquids, nasal decongestants, suck-back, application complex

Nasal spray

­Liquids, 3 – 50ml bottle, spray nozzle, fine droplets (25 – 50µm), singles dose (25 – 200µl).

Breath-actuated delivery

­Liquids and powders, tight fitting nozzle placed in nostril and metered dose is aerosolised by blowing through mouthpiece, separates oral and nasal cavities, e.g. OptiNoseTM

Electronic atomisation

­Liquids, controlled droplet size (8 - 30µm), expensive

Nasal pressurised meter-dosed inhaler

­Powders, propellant gives good dispersion, phased out for cheaper aqueous preparations

17
Q

Advantages of the nasal route

A

• Good compliance – non invasive, convenient / accessible route

  • Rapid effect
  • Avoids 1st pass metabolism / GI irritation
  • Lower dose
  • Manufacturing cost costs – i.e. no sterilisation
  • Management of chronic disorders
18
Q

Disadvantages of nasal route

A
  • Limited volume delivery (25 – 200µl)
  • Mucociliary Clearance / mucus barrier
  • Enzymic activity / metabolism
  • low permeability of hydrophilic drugs
  • Short absorption time / inconsistent absorption
  • Drug instability – peptides
  • Rebound congestion